Mikhail Blagosklonny: Aggressively Innovative Approach to Cancer and Aging

Aging and cancer are foci whose solutions are yet to be exhaustively looked into. Many options have been considered so far, and viable options keep coming up especially with the advancement in technology. One of the hypotheses developed is the use of Rapamycin. This is also called Sirolimus or by the trade name, Rapumen. The drug was first formulated in 1972 from a bacterium found in Easter Island. In the beginning, the drug was used as an anti-fungal agent. That was abandoned as soon as it was suspected to have immunosuppressant and antiproliferative properties. Today, it is used to prevent negative response by the body after a transplant. Rapamycin is also common in cancer therapy. Dr. Mikhail Blagosklonny sparked interest in the subject of the role of Target of Rapamycin signaling in aging and cancer. By addressing cellular senescence associated with aging, the drug’s properties may be the find of the decade. Rapamycin was found to rejuvenate immunity. Rapamycin was also proposed in the treatment of Alzheimer’s and muscular dystrophy. Know more about Mikhail at Philly Purge.

Cancer Treatment despite Depth of Pocket

It is undeniable that cancer has become a global menace. Dr. Blagosklonny has conducted extensive research on the prevalence of malignant cells, particularly in advanced age. Many of his papers and lectures have revealed a lot of useful information on cancer, which will be relevant for years to come. The good doctors are on a mission to treat this life-threatening disease efficiently. Most importantly, they are seeking to device a way that is affordable and much less painful to the patient. Mikhail strives to find a way that can aid in eliminating cancerous cells without distorting the healthy cells. Cancer treatment is costly, and for a long time, it has been considered a reserve for the rich. Mikhail foresees a future where it is accessible by all people regardless of their social and financial eminence. Dr. Mikhail is hopeful that his research will be a stepping-stone to innovative cancer therapies in the future. It is Blagosklonny’s fervent hope that his students and next-generation scientists will continue his work. Read Mikhail’s plans for Oncology on Healingmagic.net.

Foundation of Passion

Mikhail Blagosklonny was a professor of Oncology at Roswell Park Cancer Institute in New York up until 2016. He got his MD in Internal Medicine from the First Pavlov State Medical University of St. Petersburg. Dr. Blagasklonny also holds a Ph.D. in Experimental Medicine and Cardiology from the same institution. He was an Associate Professor at New York Medical College in 2002. This was before he left to be a Senior Scientist at Ordway Research Institute until 2009. Dr. Mikhail Blagosklonny is the editor in chief of Aging, Cell Cycle, and Oncotarget.

Shift in Thinking

In a world where cancer and age-related illnesses are paralyzing global citizens, a more proactive startegy needs be taken to find new approaches to treatment and prevention. Dr. Mikhail Blagosklonny’s work has been instrumental in these fields. He is a deservedly revered professional with a legacy that will outlive him.

Learn more: https://classroomvoices.org/understanding-oncology-through-mikhail-blagosklonny/

Categories: Cancer Research

Fabletics succeeds in reverse showrooming

Succeeding in online business is no mean feat, especially in an industry that is dominated by large brands. Few established companies are making huge profits by trading online. One such company is Amazon, which controls a substantial share of the fashion e-commerce market. Currently, Amazon controls a whopping 20 percent of the internet fashion industry.


In the last couple of years, a few companies have tried to get a share of the cake to no avail. However, the establishment of Fabletics brought competition right to the Amazon’s door. The company has already built a 250 million dollar enterprise in less than five years. Fabletics has established an activewear brand that is already doing well in the market.


Fabletics introduced a subscription-based model, which has helped the company to grow their clientele base in a short time. In this marketing model, customers are given the opportunity to apply for membership which gives them access to a portfolio of established brands. Subscribed members can also access high-quality activewear at an affordable price.


Historically, high-value brands have been defined by price and the quality of services or goods that they offer. However, the recent trends indicate that this combination is no longer feasible and it cannot guarantee success. A new combination of things such as customer experience, last-mile service, brand recognition, gamification elements and exclusive design play a crucial role in determining what high-value to a consumer is.


Fabletics is using a marketing model that is used by tech-giant companies such as the Apple and Warby Parker. The strategy seems to work well for Fabletics since they are expected to open more brick and mortar stores by the end of this year to top to the 16 stores that are spread across the country.


According to Gregg Throgmartin, Fabletics General Manager notes that the secret behind the company’s success lies in their membership model that allows them to provide customized services and trendy clothes at affordable prices. Fabletics is currently offering the most competitive prices in the market.


Fabletics success in reverse showrooming

Fabletics has succeeded in utilizing reverse showrooming. Unlike their competitors who are driven out of the market by showrooming, Fabletics have reversed the model to their advantage. In showrooming, customers browse offline and then go to purchase the products elsewhere.


Kate Hudson is the main image behind Fabletics. She is an entertainment icon who has built a great name in the entertainment industry. She has led the company through a success path where it recently won the athleisure brand. She was excited about winning the athleisure brand and promised to work harder to grow Fabletics even more.

Categories: Fashion